|
Adolopment |
Adoption-Adaptation-Development |
|
AGREE II |
Appraisal of Guidelines for Research and Evaluation Instrument |
|
ALT |
Alanine aminotransferase |
|
ALP |
alkaline phosphatase |
|
AST |
Aspartate aminotransferase |
|
BA |
Biliary atresia |
|
BASM |
Biliary atresia with splenic malformations |
|
CBD |
Common bile duct |
|
CM |
Choledochal malformation |
|
CMV |
Cytomegalovirus |
|
CPG/ CPGs |
Clinical Practice Guideline (s) |
|
DHS |
Demographic and Health Survey |
|
ERCP |
Endoscopic retrograde cholangiopancreatography |
|
EPG |
Egyptian Pediatrics Clinical Practice Guidelines Committee |
|
EPG CPG |
EPG Clinical Practice Guideline |
|
ERG |
External Review Group |
|
GAG |
Guideline Adaptation Group |
|
GALD |
Gestational alloimmune liver disease |
|
GB |
Gall bladder |
|
GDG |
Guideline Development Group |
|
GGT |
Gamma-glutamyl transferase |
|
GPS |
Good Practice Statement |
|
GRADE |
Grading of Recommendations Assessment, Development and Evaluation |
|
HIV |
Human Immunodeficiency virus |
|
IEM |
Inborn errors of metabolism |
|
MRCP |
Magnetic resonance cholangiopancreatography |
|
NIC |
Neonatal and infantile cholestasis |
|
PFIC |
Progressive familial intrahepatic cholestasis |
|
PIBD |
Paucity of intrelobular bile ducts |
|
PICO |
Population, intervention, comparison, and outcomes |
|
PIPOH |
Patient population, intervention, professionals, outcomes, and healthcare context |
|
PNALD |
Parenteral nutrition-associated cholestasis |
|
PT |
Prothrombin time |
|
RIGHT |
A Reporting Tool for Practice Guidelines in Health Care |
|
SCC |
Stool color card |
|
TSH |
Thyroid stimulating hormone |